Twenty‐five years of <i>Respirology</i>: Advances in asthma

Beasley, Richard; Gibson, Peter G.

doi:10.1111/resp.13735

Cited by 1 publication

(1 citation statement)

References 17 publications

(36 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They also reminded the reader of the ‘dark bronchodilator era’ which saw increases in mortality as a result of poorly selected high‐dose beta‐agonist use. A new era in asthma management was introduced for the present, in which asthma heterogeneity is routinely recognized to allow personalized medicine with individualized treatments targeted to identifiable treatable traits 12 . Treatable traits is an approach that addresses heterogeneity by ensuring patients are individually assessed for treatable characteristics or ‘traits’, and an individualized treatment programme is developed and implemented to target traits 13,14 .…”

Section: Personalized Medicine In Severe Asthmamentioning

confidence: 99%

Contemporary Concise Review 2020: Asthma

Wang

McDonald

2021

Respirology

View full text Add to dashboard Cite

Bushfires and coronavirus 2019 (COVID-19) were dominate features of 2020.• Patients with asthma were significantly affected by the 2019/2020 bushfire season with an increased burden compared to the general population. • Patients with controlled asthma do not appear to be at higher risk of severe COVID-19 infection or death than the general population. • Personalized medicine is proposed as the next era for asthma management, with treatable traits as a strategy to implement personalized medicine into practice. • Patient engagement in personalized medicine strategies is important and needs to be further explored. • Oral corticosteroid (OCS) use in asthma is common and contributes a major burden. OCS stewardship is recommended. • Biologic therapies reduce exacerbations of severe asthma and biomarkers can be used to predict treatment responders. • Epithelia at mucosal and cutaneous surfaces are components in asthma pathogenesis, through airway immunity and inflammation. • Dysregulation of resident microbial communities in the lung, gut and skin microbiome is relevant to asthma pathogenesis, but there are still many unknowns in this field.

show abstract

Section: Personalized Medicine In Severe Asthmamentioning

confidence: 99%